Effects of nitric oxide on notexin-induced muscle inflammatory responses

International Journal of Biological Sciences

Volumn 11, Issue 2, 2015, Pages 156-167

  Liu, Xing Hui ^a   Wu, Gang ^a   Dan Shi, Dan ^a   Zhu, Rong ^a   Zeng, Hui Jun ^a   Cao, Biao ^a   Huang, Mei Xian ^a   Liao, Hua ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; Nitric Oxide; Skeletal muscle

Indexed keywords

MUS;

INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NOTEXIN; SNAKE VENOM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; INFLAMMATION; METABOLISM; MOUSE; SKELETAL MUSCLE;

ANIMALS; CHEMOKINE CCL2; CHEMOKINE CCL3; ELAPID VENOMS; FEMALE; INFLAMMATION; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921914290     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.10283     Document Type: Article

References (37)

1. Charge S.B., and Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev. 2004; 84:209-38.
2. Porter JD, Khanna S, Kaminski HJ, et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet. 2002; 11:263-72.
3. Anderson JE. A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol Biol Cell. 2000; 11:1859-74.
4. Tatsumi R, Hattori A, Allen RE, et al. Mechanical stretch-induced activation of skeletal muscle satellite cells is dependent on nitric oxide production in vitro. Anim Sci J.2002; 73: 235-239.
5. De Paepe B, Racz GZ, Schröder JM, et al. Expression and distribution of the nitric oxide synthases in idiopathic inflammatory myopathies. Acta Neuropathol. 2004;108:37-42.
6. Filippin L, et al. The role of nitric oxide during healing of trauma to the skeletal muscle. Inflamm. Res.2011; 60: 347–356.
7. Rigamonti, E., Touvier, T., Clementi, E., et al. Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage. J. Immunol. 2013; 190:1767–1777
8. Buono R, Vantaggiato C, Pisa V, et al. Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP. Stem Cells.2012; 30:197-209
9. Hickey M.J. Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment. Clin. Sci. 2001; 100:1–12.
10. McCafferty D.M., Mudgett J.S., Swain M.G., et al. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology. 1997; 112:1022–1027
11. Rovere-Querini P, Clementi E, Brunelli S. Nitric oxide and muscle repair: multiple actions converging on therapeutic efficacy. Eur J Pharmacol.2014; 730:181-5
12. Chen R, Feng L, Ruan M, et al. Mechanical-Stretch of C2C12 Myoblasts Inhibits Expression of Toll-Like Receptor 3 (TLR3) and of Autoantigens Associated with Inflammatory Myopathies. PLoS One.2013; 8:e79930
13. Tournadre A, Lenief V, Miossec P. Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines. Arthritis Rheum.2010; 62: 2144-2151.
14. Betteridge ZE, Gunawardena H, McHugh NJ. Pathogenic mechanisms of disease in myositis: autoantigens as clues. Curr Opin Rheumatol.2009; 21:604-609.
15. Arnold L, Henry A, Poron F, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into anti-inflammatory macrophages to support myogenesis. J Exp Med. 2007;204: 1057–1069.
16. Ward C, Wong TH, Murray J, Rahman I, Haslett C, Chilvers ER, Rossi AG. Induction of human neutrophil apoptosis by nitric oxide donors: evidence for a caspase-dependent, cyclic-GMP-independent, mechanism. Biochem Pharmacol. 2000; 59(3):305-14.
17. Lu H., et al. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J.2011; 25: 3344–3355
18. Mammen AL, Casciola-Rosen LA, Hall JC, et al. Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle. Arthritis Rheum.2009; 60: 3784-3793.
19. Vázquez-Abad D, Rothfield NF. Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis. Arthritis Rheum.1996; 39:292-296.
20. Casciola-Rosen L, Nagaraju K, Plotz P, et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med.2005; 201: 591-601.
21. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol .1989; 20:224-31.
22. Confalonieri P, Oliva L, Andreetta F, et al. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. J Neuroimmunol. 2003; 142:130-36.
23. Tiidus PM. Radical species in inflammation and overtraining. Can J Physiol Pharmacol. 1998; 76: 533–538.
24. Filippin L, et al. Nitric oxide and repair of skeletal muscle injury. Nitric Oxide. 2009; 21: 157-163.
25. Tripathi P., Kashyap L., Singh V. The role of nitric oxide in inflammatory reactions. FEMS Immunol Med Microbiol. 2007; 51: 443-452.
26. Kaminski H.J, Andrade F.H. Nitric oxide: biologic effects on muscle and role in muscle diseases. Neuromuscul Disord. 2001; 11:517–524.
27. Rubinstein I, et al. Involvement of nitric oxide systemin experimental muscle crush injury. J. Clin.Invest. 1998; 101:1325–1333.
28. Tidball J.G. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol.2005; 288:R345–R353.
29. Stamler J.S., Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol. Rev. 2001;81:209–237.
30. Hohlfeld R, Engel AG. HLA expression in myoblasts. Neurology.1991; 41:2015
31. Appleyard ST, Dunn MJ, Dubowitz V, et al. Increased expres-sion of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromus-cular disorders. Lancet. 1985; 1:361-363
32. McDouall RM, Dunn MJ, Dubowitz V. Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci. 1989; 89:213-226
33. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol. 1989; 20:224-231
34. Confalonieri P, Oliva L, Andreetta F, et al. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. J Neuro-immunol. 2003; 142:130-136.
35. Brenman, J.E., Chao, D.S., Xia, H., et al. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell.1995; 82:743-752.
36. Chang W.J., Iannaccone S.T., Lau K.S., et al. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci U S A. 1996; 93:9142-7.
37. Wehling-Henricks M., Tidball J.G. Neuronal nitric oxide synthase-rescue of dystrophin/utrophin double knockout mice does not require nNOS localization to the cell membrane. PloS One.2011; 6:e25071.